Industry-specific solutions provider Honeywell has agreed to acquire Sparta Systems and its medtech and pharma quality management software for $1.3bn from New Mountain Capital.
With this acquisition, Sparta’s AI-enabled software as a service (SaaS) quality management software (QMS) offering will be merged with an enterprise performance solution, Honeywell Forge and Experion Process Knowledge System to boost value for life sciences customers in the US, Europe and Asia.
Honeywell’s global presence, Honeywell Forge and Sparta’s expertise will be used to launch novel, integrated solutions such as QMS offerings, for life sciences and other industries.
Sparta Systems’ customers include 42 of the top 50 pharma companies and 33 of the top 50 medical device companies.
Honeywell noted that its customers will benefit from advanced digital QMS solutions to aid them in proactively attaining better quality.
This will result in enhanced novel therapies, faster time to market, better business and patient outcomes, as well as efficient regulatory compliance.
Honeywell Connected Enterprise president and CEO Que Dallara said: “Sparta’s TrackWise Digital and QualityWise.ai are a welcome addition to Honeywell’s enterprise performance management software, Honeywell Forge, and will further enhance the link between quality and production data for life sciences manufacturers.
“Our combined offerings will make it easier for customers to gain critical insights from manufacturing and quality data that can improve their manufacturing processes while ensuring product quality, patient safety, and supply chain continuity.”
Honeywell will add AI and machine learning capabilities that augment human decision making to enhance TrackWise Digital QMS.
The TrackWise solution includes support for the European Union Medical Device Regulation, incorporating Manufacturing Incident Report functionality.
In addition, novel IoT-enabled connectivity between quality and operational data will be added to near real-time identification of manufacturing anomalies and triage quality events.
The deal is anticipated to close by the end of the first quarter of next year.